IP Library Granted Patent US 11,345,949
Granted Patent B2
US 11,345,949 · App. 16/318,580 · Granted May 31, 2022

Methylated control DNA

Inventors: Hatim T. Allawi (Middleton, WI); Graham P. Lidgard (Middleton, WI)
Assignee: Exact Sciences Corporation
C12Q1/6827C12Q2523/125C12Q2531/113C12Q2545/101C12Q2561/109C12Q2600/154
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,345,949
App. No.
16/318,580
Granted
May 31, 2022
Kind
B2
Abstract

Provided herein is technology relating compositions and methods for analysis of methylated DNA from a subject. The technology also relates to use of endogenous methylated DNAs as internal controls for marker gene methylation assays.

Claims (19)

1. A composition, comprising:

a) a bisulfite-converted B3GALT6 DNA comprising SEQ ID NO:2 or the full complement of SEQ ID NO:2, and

b) a pair of primers complementary to primer binding sites within SEQ ID NO:2 or the complement thereof.

2. The composition of claim 1 , further comprising a detection probe oligonucleotide, wherein the detection probe oligonucleotide comprises a region that is complementary to a portion of said DNA.

3. The composition of claim 1 , further comprising one or more of:

a detection probe oligonucleotide;

a FRET cassette;

a FEN-1 endonuclease;

a thermostable DNA polymerase.

4. The composition of claim 2 , wherein said detection probe oligonucleotide comprises a reporter molecule.

5. The composition of claim 2 , wherein said detection probe oligonucleotide comprises a flap sequence.

6. The composition of claim 4 , where said reporter molecule comprises a fluorophore.

7. A method, the method comprising:

a) treating DNA from a sample with a bisulfite reagent to produce a bisulfite-converted B3GALT6 DNA;

b) amplifying a region of said bisulfite-converted DNA using a pair of nucleic acid primers; and

c) detecting an amplified B3GALT6 DNA comprising SEQ ID NO:2 or the full complement thereof.

8. The method of claim 7 , further comprising a step of detecting the amplified bisulfite-converted B3ALT6 DNA comprising SEQ ID NO: 2 with a detection probe oligonucleotide.

9. The method of claim 8 , wherein said detection probe oligonucleotide comprises a reporter molecule.

10. The method of claim 8 , wherein said detection probe oligonucleotide comprises a flap sequence.

Assignments (5)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT RIGHTS (REEL/FRAME 69898/0249) Recorded Mar 27, 2026
From: JPMORGAN CHASE BANK, N.A.
To: EXACT SCIENCES CORPORATION
Reel/Frame 075288/0393 →
PATENT SECURITY AGREEMENT Recorded Jan 14, 2025
From: EXACT SCIENCES CORPORATION
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 069898/0249 →
MERGER Recorded Jan 14, 2022
From: EXACT SCIENCES DEVELOPMENT COMPANY, LLC
To: EXACT SCIENCES CORPORATION
Reel/Frame 058662/0416 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2019
From: ALLAWI, HATIM T.; LIDGARD, GRAHAM P.
To: EXACT SCIENCES CORPORATION
Reel/Frame 049471/0402 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2019
From: EXACT SCIENCES CORPORATION
To: EXACT SCIENCES DEVELOPMENT COMPANY, LLC
Reel/Frame 049471/0460 →
Continuity (2)
Provisional Application 62364082 · Jul 19, 2016
Related Publication 20190218601A1 · Jul 18, 2019
Cited By (6)
US 12,188,093 US 12,319,969 US 12,571,025 US 12,601,011 US 12,606,873 US 12,612,664